Results 121 to 130 of about 8,953 (196)

Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series. [PDF]

Acta Derm Venereol
Tejero-García C, Alamon Reig F, Bosch-Amate X, Carrera C, Giavedoni P, Gil Faure I, Jiménez Antón A, Mayor Ibarguren A, Usero Bárcena T, Álvarez-Salafranca M, Gamissans Cañada M, López Robles J, Martínez-Fernández S, Segura S, Sánchez-Aguilar Rojas D, Flórez Á.   +15 more
europepmc   +1 more source

Vedolizumab-induced Bullous Pemphigoid: A Case Report with Serological Evidence and Mechanistic Insights. [PDF]

Acta Derm Venereol
Feng X, Li J, Li X, Zhang Y, Li W.
europepmc   +1 more source

The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study. [PDF]

JAAD Case Rep
Domingues E.
europepmc   +1 more source

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in an Elderly Woman With Type 2 Diabetes Mellitus: A Case Report. [PDF]

Cureus
Roa Alvarez G, Shuchleib Cukiert M, Hernández Altamirano FR, Berumen Glinz C, Vega Memije ME.   +4 more
europepmc   +1 more source

Regulatory T cells in bullous pemphigoid: biological characteristics, dysfunction, and pathogenic roles. [PDF]

Front Immunol
Wang Z, Lu Y, Cui H, Zhang Y, Meng L, Chang W, Yang X, Ye J.   +7 more
europepmc   +1 more source

The Role of Accessible Hematological Markers in Bullous Pemphigoid: A Systematic Review. [PDF]

Int J Mol Sci
Małolepsza A, Juczyńska K, Woźniacka A, Brzeszczyńska J, Żebrowska A.   +4 more
europepmc   +1 more source

Expanding the Spectrum of Bullous Pemphigoid in Skin of Color. [PDF]

Indian Dermatol Online J
De D, Mehta H.
europepmc   +1 more source

Gingival-Dominant Presentation of DPP-4 Inhibitor-Associated Bullous Pemphigoid: A Case Report. [PDF]

Cureus
Fujii Y, Kataoka T, Togashi C, Ishikawa M, Kawase-Koga Y.   +4 more
europepmc   +1 more source

Bullous Pemphigoid in Children: Sustained 8-Year Remission After Short-Course Corticosteroid Therapy. [PDF]

Clin Case Rep
Wang F, Li H, Xu Y, Wang W.
europepmc   +1 more source